Shandong Xinhua Pharmaceutical Receives Drug Registration Certificate for Sevelamer Carbonate Dry Suspension

Stock News06-01

Shandong Xinhua Pharmaceutical Co., Ltd. has announced that it recently obtained the Drug Registration Certificate for Sevelamer Carbonate Dry Suspension from the National Medical Products Administration.

This product is indicated for controlling hyperphosphatemia in adult patients with chronic kidney disease (CKD) who are undergoing dialysis, as well as for adult CKD patients with serum phosphorus levels ≥1.78 mmol/L who are not on dialysis.

The approval of Sevelamer Carbonate Dry Suspension enhances the company's portfolio of preparation products and is expected to strengthen its overall competitiveness in the market.

**Shandong Xinhua (00719)**

The company's recent regulatory milestone adds a new therapeutic option to its product lineup, supporting its position in the pharmaceutical industry.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156155531?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 16:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156155531","market":"other","top_or_hot":-1,"title":"Shandong Xinhua Pharmaceutical Receives Drug Registration Certificate for Sevelamer Carbonate Dry Suspension","media":"Stock News","content":"<p>Shandong Xinhua Pharmaceutical Co., Ltd. has announced that it recently obtained the Drug Registration Certificate for Sevelamer Carbonate Dry Suspension from the National Medical Products Administration.<br><br>This product is indicated for controlling hyperphosphatemia in adult patients with chronic kidney disease (CKD) who are undergoing dialysis, as well as for adult CKD patients with serum phosphorus levels ≥1.78 mmol/L who are not on dialysis.<br><br>The approval of Sevelamer Carbonate Dry Suspension enhances the company's portfolio of preparation products and is expected to strengthen its overall competitiveness in the market.<br><br>**Shandong Xinhua (00719)**<br><br>The company's recent regulatory milestone adds a new therapeutic option to its product lineup, supporting its position in the pharmaceutical industry.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shandong Xinhua Pharmaceutical Receives Drug Registration Certificate for Sevelamer Carbonate Dry Suspension</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShandong Xinhua Pharmaceutical Receives Drug Registration Certificate for Sevelamer Carbonate Dry Suspension\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-01 16:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Xinhua Pharmaceutical Co., Ltd. has announced that it recently obtained the Drug Registration Certificate for Sevelamer Carbonate Dry Suspension from the National Medical Products Administration.<br><br>This product is indicated for controlling hyperphosphatemia in adult patients with chronic kidney disease (CKD) who are undergoing dialysis, as well as for adult CKD patients with serum phosphorus levels ≥1.78 mmol/L who are not on dialysis.<br><br>The approval of Sevelamer Carbonate Dry Suspension enhances the company's portfolio of preparation products and is expected to strengthen its overall competitiveness in the market.<br><br>**Shandong Xinhua (00719)**<br><br>The company's recent regulatory milestone adds a new therapeutic option to its product lineup, supporting its position in the pharmaceutical industry.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"","article_id":"1156155531","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156155531","pubTimestamp":1780303886,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shandong Xinhua Pharmaceutical Co., Ltd. has announced that it recently obtained the Drug Registration Certificate for Sevelamer Carbonate Dry Suspension from the National Medical Products...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","00719":"山东新华制药股份","BK1515":"抗疫概念"},"translate_title":"山东新华制药获得碳酸司维拉姆干混悬剂药品注册证书","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00719":1},"content_text":"Shandong Xinhua Pharmaceutical Co., Ltd. has announced that it recently obtained the Drug Registration Certificate for Sevelamer Carbonate Dry Suspension from the National Medical Products Administration.This product is indicated for controlling hyperphosphatemia in adult patients with chronic kidney disease (CKD) who are undergoing dialysis, as well as for adult CKD patients with serum phosphorus levels ≥1.78 mmol/L who are not on dialysis.The approval of Sevelamer Carbonate Dry Suspension enhances the company's portfolio of preparation products and is expected to strengthen its overall competitiveness in the market.**Shandong Xinhua (00719)**The company's recent regulatory milestone adds a new therapeutic option to its product lineup, supporting its position in the pharmaceutical industry.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156155531","isCrawlerRequest":true}